Skip to main content
. 2022 Nov-Dec;15(6):680–686. doi: 10.5005/jp-journals-10005-2456

Table 1.

Characteristics of included studies

Author/Year/Place Sample size (M/F) Age Intervention/Dose (M) Comparator/Dose (MK) Ease of treatment completion/behavior of child during treatment Sedation score Onset of sedation Recovery time Adverse effects Overall success
Koirala/200622/Nepal 120 2–9 years Midazolam: 0.5 mg/kg orally Combination of midazolam 0.4 mg/kg and ketamine 3 mg/kg orally MK: most convenient MK: best sedation MK: shortest time required M: shortest None
Bahetwar/201123/India 45 (M: 22, F: 23) 2–6 years Midazolam: 0.3 mg/kg intranasally MK (0.2 and 4 mg/kg, respectively) M: 72%
MK: 84%
M: 84%
MK: 89%
M: 5–10 minutes
MK: 4–10 minutes
M: 26–40 minutes
MK: 35–49 minutes
Vomiting
MK: 1
M: 69%
MK: 84%
Moreira/201318/Brazil 41 Under 36 months Oral midazolam (MS) at a dose of 1.0 mg⁄kg MK [a combination of oral midazolam (0.5 mg⁄ kg) and ketamine (3 mg⁄ kg)] OSUBRS score
During dental exam
PS: 12.5 ± 5.5
MS: 13.6 ± 4.5
MK: 12.6 ± 4.4
During treatment
PS: 12.5 ± 5.2
MS: 14.0 ± 3.8
MK: 8.6 ± 4.1
MK: longer and effective session (p = 0.04) Agitation
MK: 1
Vomiting
MK: 4
Antunes/201624/Brazil 56 Under 4 years Moderate sedation with midazolam (dose 1 mg/kg, maximum 20 mg) administered orally Moderate sedation with the association of midazolam (0.5 mg/kg, maximum 20 mg) and ketamine (3 mg/kg dose, maximum 50 mg) OSUBRS score
Quiet behavior
M: 2.9 times
MK: 4.3 times
No adverse events
Sado-Filho/201925/Brazil 84
(M: 43, F: 41)
Under 7 years Oral midazolam (MO) (1.0 mg/kg, maximum 20.0 mg) KMO: combination of ketamine (4.0 mg/kg, maximum 100.0 mg) and midazolam (0.5 mg/kg, maximum 5.0 mg) by oral route
KMIN: combination of intranasal ketamine (4.0 mg/kg, maximum 100.0 mg) and midazolam (0.2 mg/kg, maximum 5.0 mg)
OSUBRS score
Quiet behavior
MO: 10.7%
KMO: 42.9%
KMIN: 21.4%
MO: 39%
KMO: 53.6%
KMIN: 39.3%
MO: 32.1%
KMO: 46.4%
KMIN: 50.0%